1h Free Analyst Time
The diagnostic radiopharmaceuticals landscape has evolved into a cornerstone of modern healthcare, powering precise imaging and targeted therapies that revolutionize clinical decision-making. These specialized compounds bridge nuclear medicine and molecular biology, enabling visualization of physiological processes at the cellular level. As healthcare systems globally strive for improved patient outcomes and cost efficiencies, diagnostic radiopharmaceuticals deliver unparalleled sensitivity and specificity in detecting disease across cardiology, neurology, and oncology. Furthermore, advancements in cyclotron technology, automation of radiolabeling processes, and regulatory harmonization are accelerating adoption in both established and emerging markets. This introduction sets the stage for an in-depth exploration of the forces reshaping this dynamic sector, equipping stakeholders with the insights needed to navigate opportunities and challenges moving forward.Speak directly to the analyst to clarify any post sales queries you may have.
Transformative Shifts in the Diagnostic Radiopharmaceutical Landscape
The sector is undergoing a fundamental transformation driven by technological breakthroughs and shifting care pathways. First, the integration of theranostic approaches fuses diagnostic imaging with targeted radiotherapy, enabling a seamless continuum from detection to treatment planning. Concurrently, AI-driven image reconstruction and quantitative analytics are enhancing lesion detectability and reducing scan times. Supply chain innovations, including on-site cyclotron deployment and modular radiochemistry platforms, are decentralizing production and minimizing half-life constraints. Regulatory authorities are also converging around standardized quality guidelines, expediting approvals for novel tracers. Finally, a growing emphasis on personalized medicine is propelling the development of bespoke radioligands tailored to individual molecular profiles, ushering in an era where diagnostic precision dovetails with therapeutic efficacy.Cumulative Impact of United States Tariffs in 2025
Under the new United States tariff framework effective in 2025, precursor chemicals, radiolabeling kits, and cyclotron components imported from key manufacturing hubs face increased duties. This escalation elevates raw material costs, prompting manufacturers to reassess supply chains and consider vertical integration strategies. Academic institutions and contract research organizations reliant on imported tracers may experience project delays or budget overruns, potentially impeding innovation pipelines. Conversely, domestic production facilities stand to gain a competitive edge, as localized manufacturing mitigates tariff burdens and reduces lead times. To balance these dynamics, stakeholders are exploring flexible sourcing agreements, tariff engineering measures, and collaborative alliances with domestic cyclotron operators. As a result, the tariff regime is catalyzing a strategic shift toward supply chain resilience, even as it exerts upward pressure on end-user pricing.Key Insights from Market Segmentation
When examining growth by product type, fluorodeoxyglucose radiopharmaceuticals continue to dominate due to their broad clinical utility, whereas technetium-99m based agents maintain a strong presence in legacy imaging workflows. Simultaneously, radioactive antibodies are gaining traction in immuno-PET applications, and novel radioisotope tracers are entering late-stage clinical trials for targeted diagnostics. In application areas, cardiology remains a stable revenue pillar through myocardial perfusion imaging and cardiac ventriculography, while neurology is propelled by dementia protocols, epilepsy assessments, and Parkinson’s disease imaging. Oncology leads the charge with specialized protocols for breast, lung, prostate, and thyroid cancers that demand high-affinity tracers. Procedure insights reveal that PET imaging is expanding its clinical footprint at the expense of single photon emission computed tomography, and therapeutic procedures such as radioisotope therapy and targeted radiotherapy are securing new indications in liver and bone metastasis. From an end-user perspective, hospitals retain the largest share owing to integrated imaging centers, yet diagnostic centers-both independent and chain models-are capturing market share by offering fast-track appointments and specialized PET/SPECT services. Finally, within the therapeutic radiopharmaceutical category, radioembolization agents and radioimmunotherapy agents are emerging as critical tools in the oncologist’s arsenal, underscoring the convergence of diagnostic and treatment modalities.Key Regional Insights
In the Americas, robust reimbursement frameworks and established nuclear medicine infrastructure underpin sustained utilization, particularly in the United States and Canada. Across Europe, Middle East & Africa, diverse regulatory landscapes and varying reimbursement policies drive patchwork adoption rates; Western Europe leads in theranostic approvals, while the Middle East is investing in new PET centers, and Africa remains focused on capacity building. Meanwhile, Asia-Pacific is delivering the fastest uptake, fueled by government-led healthcare modernization in China, India, and Southeast Asia. Japan’s mature radiopharmaceutical ecosystem continues to innovate with novel tracers, whereas Australia and South Korea are expanding cyclotron networks to address regional demand. These regional dynamics underscore the importance of tailored market entry strategies and partnership models.Leading Company Dynamics
A range of established and emerging players are shaping the competitive environment. Advanced Accelerator Applications, a Novartis company, is advancing theranostic pipelines with PSMA-targeted ligands. Bayer AG leverages its radiochemistry expertise to expand Tc-99m offerings. Blue Earth Diagnostics Limited focuses on innovative PET tracers for prostate cancer. Bracco Imaging S.p.A. strengthens its footprint through integrated kits and generator supplies. Cardinal Health supports distribution networks for both research and clinical-grade radiopharmaceuticals. CURIUM and Curium Pharma invest heavily in cyclotron capacity expansion. GE Healthcare remains a leader in imaging equipment paired with radiotracer solutions. Global Medical Solutions (GMS) offers modular production platforms to decentralized sites. Iba Radiopharma Solutions pioneers bespoke radioisotopes for emerging applications. The Institute of Nuclear Medicine & Allied Sciences propels R&D in novel radiolabeling techniques. Lantheus Medical Imaging, Inc. combines agent development with clinical trials infrastructure. Nordion (Canada) Inc. supplies key radioisotopes and generator systems. NorthStar Medical Radioisotopes, LLC focuses on domestic Tc-99m production. Radiologix Inc. specializes in custom tracer manufacturing. Radiomedix Inc. accelerates peptide radioligand development. Siemens Healthineers integrates PET/MRI solutions with software analytics. SOFIE Biosciences pioneers kit-based automation for radiochemistry, and Telix Pharmaceuticals Limited advances theranostic radioligands through late-stage development.Actionable Recommendations for Industry Leaders
- Invest in localized production by establishing or partnering with regional cyclotron facilities to mitigate tariff impact and shorten supply chains.
- Diversify raw material sourcing through multi-supplier agreements and alternative precursor routes to guard against geopolitical disruptions and regulatory shifts.
- Prioritize R&D in theranostic and peptide-based tracers that align with personalized medicine initiatives, unlocking new clinical applications and reimbursement pathways.
- Engage proactively with regulatory bodies to streamline approval processes, leverage accelerated pathways, and contribute to harmonized quality standards.
- Implement digital tracking and analytics platforms to optimize batch yields, monitor cold chain integrity, and forecast demand at the facility level.
- Pursue cross-industry collaborations-spanning pharma, device OEMs, and academic centers-to co-develop integrated diagnostic-therapeutic solutions.
- Champion sustainability by reducing radioactive waste through generator recycling programs and greener radiochemistry methodologies.
Conclusion and Strategic Imperatives
The diagnostic radiopharmaceuticals sector stands at an inflection point, propelled by convergence of personalized medicine, regulatory alignment, and technological breakthroughs. While tariff pressures pose near-term challenges, they catalyze supply chain resilience and local innovation. By harnessing segmentation insights across product types, applications, procedures, and end-users, companies can refine their strategic focus and accelerate adoption. Regional nuances highlight the need for bespoke market approaches, while competitive analysis underscores collaboration as a pathway to shared success. Ultimately, stakeholders who proactively implement the recommendations outlined will be best positioned to drive sustainable growth, enhance patient outcomes, and shape the future of molecular imaging and targeted therapy.Market Segmentation & Coverage
This research report categorizes the Diagnostic Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-segmentations:
- Fluorodeoxyglucose (FDG) Radiopharmaceuticals
- Radioactive Antibodies
- Radioisotope Tracers
- Technetium-99m (Tc-99m) Based Radiopharmaceuticals
- Cardiology
- Cardiac Ventriculography
- Myocardial Perfusion Imaging
- Neurology
- Dementia
- Epilepsy
- Parkinson's Disease
- Oncology
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Thyroid Cancer
- Diagnostic Imaging
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Therapeutic Procedures
- Radioisotope Therapy
- Targeted Radiotherapy
- Academic & Research Institutes
- Military Research Facilities
- University Research Centers
- Diagnostic Centers
- Chain Diagnostic Centers
- Independent Diagnostic Centers
- Hospitals
- Private Hospitals
- Public Hospitals
- Therapeutic Radiopharmaceuticals
- Radioembolization Agents
- Radioimmunotherapy Agents
This research report categorizes the Diagnostic Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-regions:
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
This research report categorizes the Diagnostic Radiopharmaceuticals Market to delves into recent significant developments and analyze trends in each of the following companies:
- Advanced Accelerator Applications (AAA), a Novartis Company
- Bayer AG
- Blue Earth Diagnostics Limited
- Bracco Imaging S.p.A.
- Cardinal Health
- CURIUM
- Curium Pharma
- GE Healthcare
- Global Medical Solutions (GMS)
- Iba Radiopharma Solutions
- Institute of Nuclear Medicine & Allied Sciences
- Lantheus Medical Imaging, Inc.
- Nordion (Canada) Inc.
- NorthStar Medical Radioisotopes, LLC
- Radiologix Inc.
- Radiomedix Inc.
- Siemens Healthineers
- SOFIE Biosciences
- Telix Pharmaceuticals Limited
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diagnostic Radiopharmaceuticals Market, by Product Type
8.1. Introduction
8.2. Fluorodeoxyglucose (FDG) Radiopharmaceuticals
8.3. Radioactive Antibodies
8.4. Radioisotope Tracers
8.5. Technetium-99m (Tc-99m) Based Radiopharmaceuticals
9. Diagnostic Radiopharmaceuticals Market, by Application
9.1. Introduction
9.2. Cardiology
9.2.1. Cardiac Ventriculography
9.2.2. Myocardial Perfusion Imaging
9.3. Neurology
9.3.1. Dementia
9.3.2. Epilepsy
9.3.3. Parkinson's Disease
9.4. Oncology
9.4.1. Breast Cancer
9.4.2. Lung Cancer
9.4.3. Prostate Cancer
9.4.4. Thyroid Cancer
10. Diagnostic Radiopharmaceuticals Market, by Procedure Type
10.1. Introduction
10.2. Diagnostic Imaging
10.2.1. Positron Emission Tomography (PET)
10.2.2. Single Photon Emission Computed Tomography (SPECT)
10.3. Therapeutic Procedures
10.3.1. Radioisotope Therapy
10.3.2. Targeted Radiotherapy
11. Diagnostic Radiopharmaceuticals Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.2.1. Military Research Facilities
11.2.2. University Research Centers
11.3. Diagnostic Centers
11.3.1. Chain Diagnostic Centers
11.3.2. Independent Diagnostic Centers
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Diagnostic Radiopharmaceuticals Market, by Radiopharmaceutical Type
12.1. Introduction
12.2. Therapeutic Radiopharmaceuticals
12.2.1. Radioembolization Agents
12.2.2. Radioimmunotherapy Agents
13. Americas Diagnostic Radiopharmaceuticals Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Diagnostic Radiopharmaceuticals Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Diagnostic Radiopharmaceuticals Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Accelerator Applications (AAA), a Novartis Company
16.3.2. Bayer AG
16.3.3. Blue Earth Diagnostics Limited
16.3.4. Bracco Imaging S.p.A.
16.3.5. Cardinal Health
16.3.6. CURIUM
16.3.7. Curium Pharma
16.3.8. GE Healthcare
16.3.9. Global Medical Solutions (GMS)
16.3.10. Iba Radiopharma Solutions
16.3.11. Institute of Nuclear Medicine & Allied Sciences
16.3.12. Lantheus Medical Imaging, Inc.
16.3.13. Nordion (Canada) Inc.
16.3.14. NorthStar Medical Radioisotopes, LLC
16.3.15. Radiologix Inc.
16.3.16. Radiomedix Inc.
16.3.17. Siemens Healthineers
16.3.18. SOFIE Biosciences
16.3.19. Telix Pharmaceuticals Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DIAGNOSTIC RADIOPHARMACEUTICALS MARKET MULTI-CURRENCY
FIGURE 2. DIAGNOSTIC RADIOPHARMACEUTICALS MARKET MULTI-LANGUAGE
FIGURE 3. DIAGNOSTIC RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIAGNOSTIC RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORODEOXYGLUCOSE (FDG) RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOACTIVE ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TRACERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-99M (TC-99M) BASED RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIAC VENTRICULOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY TARGETED RADIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY MILITARY RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY UNIVERSITY RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CHAIN DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY INDEPENDENT DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOEMBOLIZATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOIMMUNOTHERAPY AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 97. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 100. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 101. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 102. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 103. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 104. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 105. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 107. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 108. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 110. CANADA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 118. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 121. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 122. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 169. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 172. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 173. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 174. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 175. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 176. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 177. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 179. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 180. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 182. CHINA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 183. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 186. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 187. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 188. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 189. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 190. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 191. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 193. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 194. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 195. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 196. INDIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 211. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 214. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 215. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 216. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 217. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 218. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 219. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 221. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 223. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 224. JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 278. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 284. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 285. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 286. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 287. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
TABLE 288. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 289. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 291. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 292. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 293. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOPHARMACEUTICAL TYPE, 2018-2030 (USD MILLION)
TABLE 294. TAIWAN DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 295. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS M
Companies Mentioned
- Advanced Accelerator Applications (AAA), a Novartis Company
- Bayer AG
- Blue Earth Diagnostics Limited
- Bracco Imaging S.p.A.
- Cardinal Health
- CURIUM
- Curium Pharma
- GE Healthcare
- Global Medical Solutions (GMS)
- Iba Radiopharma Solutions
- Institute of Nuclear Medicine & Allied Sciences
- Lantheus Medical Imaging, Inc.
- Nordion (Canada) Inc.
- NorthStar Medical Radioisotopes, LLC
- Radiologix Inc.
- Radiomedix Inc.
- Siemens Healthineers
- SOFIE Biosciences
- Telix Pharmaceuticals Limited
Methodology
LOADING...
